Search - tctmd.com

Displaying 381 - 400 of 637

Sort: Relevancy | Date

News Daily News

Un Pequeño Estudio OCT Sugiere una Respuesta Favorable a Largo Plazo al Andamiaje Bioabsorbible

December 04, 2014

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

News Industry News

Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital Readmissions

November 15, 2014

News Daily News

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

November 06, 2014

News Daily News

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

November 06, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Daily News

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Caitlin E. Cox

October 03, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

Presentation TCT 2014

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq

September 16, 2014

Presentation TCT 2014

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Stephane Cook

September 16, 2014

News Industry News

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

September 16, 2014

Presentation TCT 2014

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Ran Kornowski

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gary M. Ansel

September 15, 2014

Presentation TCT 2014

VELOCITY: A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Presenter: Stefan K. James, Cindy L. Grines, Gregg W. Stone

September 15, 2014

Presentation TCT 2014

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Antonio Colombo

September 15, 2014

Presentation TCT 2014

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Nikolaus Sarafoff

September 15, 2014

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

Advertisement

Un Pequeño Estudio OCT Sugiere una Respuesta Favorable a Largo Plazo al Andamiaje Bioabsorbible

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital Readmissions

Un Estudio OCT Sugiere que ‘Tapar’ la Placa es Más Seguro con BRS que con SMD

OCT研究表明，采用BRS时的斑块“帽子形成”比BMS更安全

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

VELOCITY: A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

ISAR-TRIPLE: A Prospective, Randomized Trial of Six Weeks Versus Six Months of Clopidogrel in Patients Treated with Concomitant Aspirin and Oral Anticoagulant Therapy Following Coronary Drug-Eluting Stent Implantation

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content